Cargando…
One‐year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes
INTRODUCTION: This study aimed to investigate the sustained safety and efficacy of insulin treatment simplification with IDegLira in patients with type 2 diabetes and an HbA1c ≤ 7.5% (58 mmol/mol) during a 12‐month follow‐up. METHODS: Seventy‐two adults with type 2 diabetes and an HbA1c ≤ 7.5% (58 m...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836254/ https://www.ncbi.nlm.nih.gov/pubmed/36461758 http://dx.doi.org/10.1002/edm2.390 |